Replies to post #135540 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

The exact quote was:

Our US biotech holdings were also hit hard. The month’s largest detractor was Northwest Biotherapeutics, after rumours that the clinical trial of its DCVax-L oncology treatment had been suspended. The company has confirmed that the suspension related simply to the recruitment of new patients and was a temporary measure while regulatory information was submitted, in line with clinical protocols. The trial is continuing and we see nothing untoward in this development.

Yes, he did say he saw nothing wrong.

But he also says he was told it was temporary while they submitted some regulatory info. Which is certainly at odds with an enrollment hold based on success making further recruitment unethical.

[GoodGuyBill]

Just Google "Neil Woodford" and "nothing untoward". lots of links.


1. http://www.whatinvestment.co.uk/neil-woodford-the-one-uk-share-i-have-been-buying-more-of-this-month-2493181/

Our US biotech holdings were also hit hard. The month’s largest detractor was Northwest Biotherapeutics, after rumours that the clinical trial of its DCVax-L oncology treatment had been suspended. The company has confirmed that the suspension related simply to the recruitment of new patients and was a temporary measure while regulatory information was submitted, in line with clinical protocols. The trial is continuing and we see nothing untoward in this development.

2. http://www.whatinvestment.co.uk/neil-woodford-the-one-uk-share-i-have-been-buying-more-of-this-month-2493181/

Our US biotech holdings were also hit hard. The month’s largest detractor was Northwest Biotherapeutics, after rumours that the clinical trial of its DCVax-L oncology treatment had been suspended. The company has confirmed that the suspension related simply to the recruitment of new patients and was a temporary measure while regulatory information was submitted, in line with clinical protocols. The trial is continuing and we see nothing untoward in this development.